tiprankstipranks
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market
ARTL
Artelo Biosciences
RESEARCH TOOLSreports

Artelo Biosciences (ARTL) Income Statement

578 Followers

Artelo Biosciences Income Statement

Last quarter (Q4 2025), Artelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Artelo Biosciences's net income was $-4.17M. See Artelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Aug 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.40M$ 10.11M$ 9.93M$ 10.29M$ 7.44M
Depreciation and Amortization
$ 146.00K$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -12.54M$ -10.11M$ -9.93M$ -10.08M$ -7.44M
Operating Income
$ -11.40M$ -10.11M$ -9.93M$ -10.29M$ -7.44M
Other Income/Expenses
$ -1.48M$ 282.00K$ 641.00K$ 204.00K$ 4.00K
Pretax Income
$ -12.88M$ -9.83M$ -9.29M$ -10.08M$ -7.44M
Net Income
$ -12.88M$ -9.83M$ -9.29M$ -10.08M$ -7.44M
Per Share Metrics
Basic EPS
$ -5.47$ -1.02$ -1.05$ -1.16$ -1.99
Diluted EPS
$ -5.47$ -1.02$ -1.05$ -1.16$ -1.99
Weighted Average Shares Outstanding
 2.36M 9.67M 8.88M 1.42M 622.50K
Weighted Average Shares Outstanding (Diluted)
 2.36M 9.67M 8.88M 1.42M 622.50K
Currency in USD

Artelo Biosciences Earnings and Revenue History